Application of Nanomaterials as an Advanced Strategy for the Diagnosis, Prevention, and Treatment of Viral Diseases
Open Access
- 27 September 2021
- journal article
- review article
- Published by MDPI AG in Pharmaceutics
- Vol. 13 (10) , 1570
Abstract
The coronavirus disease (COVID-19) pandemic poses serious global health concerns with the continued emergence of new variants. The periodic outbreak of novel emerging and re-emerging infectious pathogens has elevated concerns and challenges for the future. To develop mitigation strategies against infectious diseases, nano-based approaches are being increasingly applied in diagnostic systems, prophylactic vaccines, and therapeutics. This review presents the properties of various nanoplatforms and discusses their role in the development of sensors, vectors, delivery agents, intrinsic immunostimulants, and viral inhibitors. Advanced nanomedical applications for infectious diseases have been highlighted. Moreover, physicochemical properties that confer physiological advantages and contribute to the control and inhibition of infectious diseases have been discussed. Safety concerns limit the commercial production and clinical use of these technologies in humans; however, overcoming these limitations may enable the use of nanomaterials to resolve current infection control issues via application of nanomaterials as a platform for the diagnosis, prevention, and treatment of viral diseases.Keywords
Funding Information
- National Research Foundation of Korea (NRF-2019R1I1A1A01057005, NRF-2018M3A9E2022819, NRF-2021M3E5E3083400, NRF-2021M3E5E3080565)
This publication has 189 references indexed in Scilit:
- Immune enhancing properties of the novel Matrix-M™ adjuvant leads to potentiated immune responses to an influenza vaccine in miceVaccine, 2013
- Antiviral activity of silver nanoparticle/chitosan composites against H1N1 influenza A virusDiscover Nano, 2013
- A vaccine strategy that protects against genital herpes by establishing local memory T cellsNature, 2012
- Polyethyleneimine is a potent mucosal adjuvant for viral glycoprotein antigensNature Biotechnology, 2012
- Matrix-M™ Adjuvant Induces Local Recruitment, Activation and Maturation of Central Immune Cells in Absence of AntigenPLOS ONE, 2012
- Cross-presentation by dendritic cellsNature Reviews Immunology, 2012
- Development and evaluation of AS03, an Adjuvant System containing α-tocopherol and squalene in an oil-in-water emulsionExpert Review of Vaccines, 2012
- A Novel Anti-Influenza Copper Oxide Containing Respiratory Face MaskPLOS ONE, 2010
- Gold nanorod delivery of an ssRNA immune activator inhibits pandemic H1N1 influenza viral replicationProceedings of the National Academy of Sciences, 2010
- Application of nanotechnologies for improved immune response against infectious diseases in the developing worldAdvanced Drug Delivery Reviews, 2010